Effect of atropine on tracheal mucociliary clearance and bacterial counts

M. E. Whiteside, I. Lauredo, G. A. Chapman, K. R. Ratzan, W. M. Abraham, Adam Wanner

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The purpose of this study was to determine if atropine, which has been shown to alter mucosal function, prolongs the persistence of inhaled bacteria in the trachea. In conscious sheep, bacterial counts in the trachea were determined by quantitative sterile brush cultures obtained before and serially after a controlled inhalation challenge, with an aerosolized solution containing P. hemolytica (108 CFU · ml-1). The same animals were studied on two days, once without (control day) and once before and during intramuscular administraion of 0.2 mg · kg-1 atropine sulfate at hourly intervals for up to 10 h (atropine day). On the control and atropine days, bacterial counts were zero before, and between 5 x 105 and 1.6 x 107 CFU · ml-1 immediately after inhalation of P. hemolytica. During the first 2 h after challenge, there was a similar semilogarithmic decline in bacterial counts on the control and atropine days despite the fact that mean tracheal mucociliary transport velocity remained unchanged on the control day, and ranged between 32% and 62% of baseline (p < 0.05) during the 6-10 h post-drug observation period on the atropine day. However, the time to achieve sterility on the control day was ≤ 8 h in all animals, and ≥ 8 h on the atropine day. We conclude that atropine prolongs the persistence of viable bacteria in the trachea. This effect of atropine may be related to an impairment of mucociliary clearance or to other alterations in mucosal function.

Original languageEnglish
Pages (from-to)347-351
Number of pages5
JournalClinical Respiratory Physiology
Volume20
Issue number4
StatePublished - Nov 1 1984
Externally publishedYes

Fingerprint

Mucociliary Clearance
Bacterial Load
Atropine
Trachea
Inhalation
Bacteria
Infertility
Sheep
Observation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Whiteside, M. E., Lauredo, I., Chapman, G. A., Ratzan, K. R., Abraham, W. M., & Wanner, A. (1984). Effect of atropine on tracheal mucociliary clearance and bacterial counts. Clinical Respiratory Physiology, 20(4), 347-351.

Effect of atropine on tracheal mucociliary clearance and bacterial counts. / Whiteside, M. E.; Lauredo, I.; Chapman, G. A.; Ratzan, K. R.; Abraham, W. M.; Wanner, Adam.

In: Clinical Respiratory Physiology, Vol. 20, No. 4, 01.11.1984, p. 347-351.

Research output: Contribution to journalArticle

Whiteside, ME, Lauredo, I, Chapman, GA, Ratzan, KR, Abraham, WM & Wanner, A 1984, 'Effect of atropine on tracheal mucociliary clearance and bacterial counts', Clinical Respiratory Physiology, vol. 20, no. 4, pp. 347-351.
Whiteside ME, Lauredo I, Chapman GA, Ratzan KR, Abraham WM, Wanner A. Effect of atropine on tracheal mucociliary clearance and bacterial counts. Clinical Respiratory Physiology. 1984 Nov 1;20(4):347-351.
Whiteside, M. E. ; Lauredo, I. ; Chapman, G. A. ; Ratzan, K. R. ; Abraham, W. M. ; Wanner, Adam. / Effect of atropine on tracheal mucociliary clearance and bacterial counts. In: Clinical Respiratory Physiology. 1984 ; Vol. 20, No. 4. pp. 347-351.
@article{a20158b559984bc88c479774081c65d9,
title = "Effect of atropine on tracheal mucociliary clearance and bacterial counts",
abstract = "The purpose of this study was to determine if atropine, which has been shown to alter mucosal function, prolongs the persistence of inhaled bacteria in the trachea. In conscious sheep, bacterial counts in the trachea were determined by quantitative sterile brush cultures obtained before and serially after a controlled inhalation challenge, with an aerosolized solution containing P. hemolytica (108 CFU · ml-1). The same animals were studied on two days, once without (control day) and once before and during intramuscular administraion of 0.2 mg · kg-1 atropine sulfate at hourly intervals for up to 10 h (atropine day). On the control and atropine days, bacterial counts were zero before, and between 5 x 105 and 1.6 x 107 CFU · ml-1 immediately after inhalation of P. hemolytica. During the first 2 h after challenge, there was a similar semilogarithmic decline in bacterial counts on the control and atropine days despite the fact that mean tracheal mucociliary transport velocity remained unchanged on the control day, and ranged between 32{\%} and 62{\%} of baseline (p < 0.05) during the 6-10 h post-drug observation period on the atropine day. However, the time to achieve sterility on the control day was ≤ 8 h in all animals, and ≥ 8 h on the atropine day. We conclude that atropine prolongs the persistence of viable bacteria in the trachea. This effect of atropine may be related to an impairment of mucociliary clearance or to other alterations in mucosal function.",
author = "Whiteside, {M. E.} and I. Lauredo and Chapman, {G. A.} and Ratzan, {K. R.} and Abraham, {W. M.} and Adam Wanner",
year = "1984",
month = "11",
day = "1",
language = "English",
volume = "20",
pages = "347--351",
journal = "Clinical Respiratory Physiology",
issn = "0272-7587",
publisher = "Pergamon Press Ltd.",
number = "4",

}

TY - JOUR

T1 - Effect of atropine on tracheal mucociliary clearance and bacterial counts

AU - Whiteside, M. E.

AU - Lauredo, I.

AU - Chapman, G. A.

AU - Ratzan, K. R.

AU - Abraham, W. M.

AU - Wanner, Adam

PY - 1984/11/1

Y1 - 1984/11/1

N2 - The purpose of this study was to determine if atropine, which has been shown to alter mucosal function, prolongs the persistence of inhaled bacteria in the trachea. In conscious sheep, bacterial counts in the trachea were determined by quantitative sterile brush cultures obtained before and serially after a controlled inhalation challenge, with an aerosolized solution containing P. hemolytica (108 CFU · ml-1). The same animals were studied on two days, once without (control day) and once before and during intramuscular administraion of 0.2 mg · kg-1 atropine sulfate at hourly intervals for up to 10 h (atropine day). On the control and atropine days, bacterial counts were zero before, and between 5 x 105 and 1.6 x 107 CFU · ml-1 immediately after inhalation of P. hemolytica. During the first 2 h after challenge, there was a similar semilogarithmic decline in bacterial counts on the control and atropine days despite the fact that mean tracheal mucociliary transport velocity remained unchanged on the control day, and ranged between 32% and 62% of baseline (p < 0.05) during the 6-10 h post-drug observation period on the atropine day. However, the time to achieve sterility on the control day was ≤ 8 h in all animals, and ≥ 8 h on the atropine day. We conclude that atropine prolongs the persistence of viable bacteria in the trachea. This effect of atropine may be related to an impairment of mucociliary clearance or to other alterations in mucosal function.

AB - The purpose of this study was to determine if atropine, which has been shown to alter mucosal function, prolongs the persistence of inhaled bacteria in the trachea. In conscious sheep, bacterial counts in the trachea were determined by quantitative sterile brush cultures obtained before and serially after a controlled inhalation challenge, with an aerosolized solution containing P. hemolytica (108 CFU · ml-1). The same animals were studied on two days, once without (control day) and once before and during intramuscular administraion of 0.2 mg · kg-1 atropine sulfate at hourly intervals for up to 10 h (atropine day). On the control and atropine days, bacterial counts were zero before, and between 5 x 105 and 1.6 x 107 CFU · ml-1 immediately after inhalation of P. hemolytica. During the first 2 h after challenge, there was a similar semilogarithmic decline in bacterial counts on the control and atropine days despite the fact that mean tracheal mucociliary transport velocity remained unchanged on the control day, and ranged between 32% and 62% of baseline (p < 0.05) during the 6-10 h post-drug observation period on the atropine day. However, the time to achieve sterility on the control day was ≤ 8 h in all animals, and ≥ 8 h on the atropine day. We conclude that atropine prolongs the persistence of viable bacteria in the trachea. This effect of atropine may be related to an impairment of mucociliary clearance or to other alterations in mucosal function.

UR - http://www.scopus.com/inward/record.url?scp=0021168226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021168226&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 347

EP - 351

JO - Clinical Respiratory Physiology

JF - Clinical Respiratory Physiology

SN - 0272-7587

IS - 4

ER -